First Patient Treated In Neuralstem China Stem Cell Trial To Treat Stroke … – EIN News (press release)
|
First Patient Treated In Neuralstem China Stem Cell Trial To Treat Stroke …
EIN News (press release) 13, 2014 /PRNewswire/ — Neuralstem, Inc. (NYSE MKT: CUR) announced that the first patient was treated in the Phase I/II NSI-566 stem cell trial to treat motor deficits from ischemic stroke at BaYi Brain Hospital in Beijing, China. The patient received … |
